Levitee Labs (OTCPK:LVTT.F) - Stock Price, News & Analysis

LVTT.F Stock Overview

A multidisciplinary integrative wellness company, provides evidence-based alternative medicines and novel psychedelic therapies. More details

LVTT.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($538K)

Shares are highly illiquid

Has not reported any financial data

Levitee Labs Inc. Competitors

Kid Castle Educational

OTCPK:KDCE

US$357.2k

AmeriCann

OTCPK:ACAN

US$542.7k

SciSparc

NasdaqCM:SPRC

US$868.9k

TFF Pharmaceuticals

NasdaqCM:TFFP

US$1.4m

Price History & Performance

Summary of all time highs, changes and price drops for Levitee Labs
Historical stock prices
Current Share Price	CA$0.000001
52 Week High	CA$0.000001
52 Week Low	CA$0.000001
Beta	0
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	-100.00%
5 Year Change	n/a
Change since IPO	-100.00%

Recent updates

Shareholder Returns

	LVTT.F	US Pharmaceuticals	US Market
7D	0%	4.2%	2.0%
1Y	n/a	13.7%	32.4%

Return vs Industry: Insufficient data to determine how LVTT.F performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how LVTT.F performed against the US Market.

Price Volatility

Is LVTT.F's price volatile compared to industry and market?
LVTT.F volatility
LVTT.F Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.7%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.9%
10% least volatile stocks in US Market	3.1%

Stable Share Price: LVTT.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine LVTT.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2019	n/a	David Bentil	www.leviteelabs.com

Levitee Labs Inc., a multidisciplinary integrative wellness company, provides evidence-based alternative medicines and novel psychedelic therapies. The company operates through two segments, Medical Services and Selling Products. It offers treatments and medications for substance use disorders and chronic pain, such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome, as well as hepatitis-C and mental health conditions.

Levitee Labs Inc. Fundamentals Summary

How do Levitee Labs's earnings and revenue compare to its market cap?
LVTT.F fundamental statistics
Market cap	US$382.48k
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is LVTT.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LVTT.F income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did LVTT.F perform over the long term?

See historical performance and comparison

Levitee Labs OTCPK:LVTT.F Stock Report